Edentree Asset Management LTD Autolus Therapeutics PLC Transaction History
Edentree Asset Management LTD
- $298 Billion
- Q1 2025
A detailed history of Edentree Asset Management LTD transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Edentree Asset Management LTD holds 300,000 shares of AUTL stock, worth $720,000. This represents 0.16% of its overall portfolio holdings.
Number of Shares
300,000Holding current value
$720,000% of portfolio
0.16%Shares
2 transactions
Others Institutions Holding AUTL
# of Institutions
99Shares Held
163MCall Options Held
0Put Options Held
88.3K-
Wellington Management Group LLP Boston, MA27.1MShares$65 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$49.2 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$42.8 Million0.97% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$39.9 Million97.79% of portfolio
-
Armistice Capital, LLC New York, NY11MShares$26.4 Million0.26% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $218M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...